Analysis of Inventory
Paying users area
Try for free
GlaxoSmithKline PLC pages available for free this week:
- Balance Sheet: Assets
- Cash Flow Statement
- Analysis of Profitability Ratios
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
The data is hidden behind: . Unhide it.
Get 1-month access to GlaxoSmithKline PLC for $22.49, or
get full access to the entire website for at least 3 months from $62.19.
This is a one-time payment. There is no automatic renewal.
We accept:
Inventory Disclosure
GlaxoSmithKline PLC, balance sheet: inventory
US$ in millions, translated from GBP £
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Raw materials and consumables | |||||||||||
| Work in progress | |||||||||||
| Finished goods | |||||||||||
| Inventories |
Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).
| Item | Description | The company |
|---|---|---|
| Inventories | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. | GlaxoSmithKline PLC inventories increased from 2012 to 2013 and from 2013 to 2014. |